Evercore ISI maintains CVS Health stock rating amid spinoff reports
Covered in this story
What has happened since
- CVS Health is up 11.7% since this was published, 10 days ago.
- Evercore is down 4.7% since this was published, 10 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Evercore ISI’s $125 target on $CVS is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.
Evercore ISI’s track record →Analyst targets on CVS Health
- Raymond James: at $83.8 · target $103 by Nov 2027 · Outperform via Investing.com
- TD Cowen: at $80 · target $110 by Nov 2027 · Buy via Investing.com
- Mizuho: at $80 · target $120 by Nov 2027 · Outperform via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CVS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on CVS Health →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.